Pharmacological management of hypertensive emergencies and urgencies: focus on newer agents

Bibliography

• Chobanian AV, Bakris GL, Black HR, Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003;42:1206-52
   PubMed Web of Science ®Google Scholar
• Agabiti-Rosei E, Salvetti M, Farsang C. European Society of Hypertension Scientific Newsletter: treatment of hypertensive urgencies and emergencies. J Hypertens 2006;24:2482-5
   PubMed Web of Science ®Google Scholar
• Vidt DG. Hypertensive crises: emergencies and urgencies. J Clin Hypertens (Greenwich) 2004;6:520-5
   PubMedGoogle Scholar
• Flanigan JS, Vitberg D. Hypertensive emergency and severe hypertension: what to treat, who to treat, and how to treat. Med Clin North Am 2006;90:439-51
   PubMed Web of Science ®Google Scholar
• Varon J. The diagnosis and treatment of hypertensive crises. Postgrad Med 2009;121:5-13
   PubMed Web of Science ®Google Scholar
• Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet 2000;356:411-17
   PubMed Web of Science ®Google Scholar
• Elliott WJ. Clinical features and management of selected hypertensive emergencies. J Clin Hypertens (Greenwich) 2004;6:587-92
   PubMedGoogle Scholar
• Keith NM, Wagener HP, Kernohan JW. The syndrome of malignant hypertension. Arch Intern Med 1928;41:141-53
   Google Scholar
• Mancia G, De Backer G, Dominiczak A, 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105-87
   PubMed Web of Science ®Google Scholar
• Kaplan NM. Hypertensive crises. In: Kaplan NM, editor. Clinical Hypertension. 9th edition. Lippincott, Williams & Wilkins; Philadelphia, PA: 2006. p. 311-24
   Google Scholar
• Elliott WJ. Clinical features in the management of selected hypertensive emergencies. Prog Cardiovasc Dis 2006;48:316-25
   PubMed Web of Science ®Google Scholar
• Tisdale JE, Huang MB, Borzak S. Risk factors for hypertensive crisis: importance of out-patient blood pressure control. Fam Pract 2004;21:420-4
   PubMed Web of Science ®Google Scholar
• Strandgaard S, Olesen J, Skinhoj E, Lassen NA. Autoregulation of brain circulation in severe arterial hypertension. Br Med J 1973;1:507-10
   PubMed Web of Science ®Google Scholar
• Bidani AK and Griffin KA. Pathophysiology of hypertensive renal damage: implications for therapy. Hypertension 2004;44:595-601
   PubMed Web of Science ®Google Scholar
• Ault MJ and Ellrodt AG. Pathophysiological events leading to the end-organ effects of acute hypertension. Am J Emerg Med 1985;3:10-15
   PubMed Web of Science ®Google Scholar
• Wallach R, Karp RB, Reves JG, Pathogenesis of paroxysmal hypertension developing during and after coronary bypass surgery: a study of hemodynamic and humoral factors. Am J Cardiol 1980;46:559-65
   PubMed Web of Science ®Google Scholar
• Marik PE, Rivera R. Hypertensive emergencies: an update. Curr Opin Crit Care 2011;17:569-80
   PubMed Web of Science ®Google Scholar
• Bagrov AY, Shapiro JI, Fedorova OV. Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets. Pharmacol Rev 2009;61:9-38
   PubMed Web of Science ®Google Scholar
• Schoner W, Scheiner-Bobis G. Endogenous and exogenous cardiac glycosides and their mechanisms of action. Am J Cardiovasc Drugs 2007;7:173-89
   PubMed Web of Science ®Google Scholar
• Fedorova OV, Tapilskaya NI, Bzhelyansky AM, Interaction of Digibind with endogenous cardiotonic steroids from preeclamptic placentae. J Hypertens 2010;28:361-6
   PubMed Web of Science ®Google Scholar
• van den Born BJ, van der Hoeven NV, Groot E, Association between thrombotic microangiopathy and reduced ADAMTS13 activity in malignant hypertension. Hypertension 2008;51:862-6
   PubMed Web of Science ®Google Scholar
• van den Born BJ, Lowenberg EC, van der Hoeven NV, Endothelial dysfunction, platelet activation, thrombogenesis and fibrinolysis in patients with hypertensive crisis. J Hypertens 2011;29:922-7
   PubMed Web of Science ®Google Scholar
• Papadopoulos DP, Mourouzis I, Thomopoulos C, Hypertension crisis. Blood Press 2010;19:328-36
   PubMed Web of Science ®Google Scholar
• Zampaglione B, Pascale C, Marchisio M, Cavallo-Perin P. Hypertensive urgencies and emergencies. Prevalence and clinical presentation. Hypertension 1996;27:144-7
   PubMed Web of Science ®Google Scholar
• Martin JF, Higashiama E, Garcia E, Hypertensive crisis profile. Prevalence and clinical presentation. Arq Bras Cardiol 2004;83:131-6
   PubMedGoogle Scholar
• Katz JN, Gore JM, Amin A, Practice patterns, outcomes, and end-organ dysfunction for patients with acute severe hypertension: the Studying the Treatment of Acute hyperTension (STAT) registry. Am Heart J 2009;158:599-606
   PubMed Web of Science ®Google Scholar
• Lane DA, Lip GY, Beevers DG. Improving survival of malignant hypertension patients over 40 years. Am J Hypertens 2009;22:1199-204
   PubMed Web of Science ®Google Scholar
• Shea S, Misra D, Ehrlich MH, Predisposing factors for severe, uncontrolled hypertension in an inner-city minority population. N Engl J Med 1992;327:776-81
   PubMed Web of Science ®Google Scholar
• Moser M, Hebert PR. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol 1996;27:1214-18
   PubMed Web of Science ®Google Scholar
• Saguner AM, Dur S, Perrig M, Risk factors promoting hypertensive crises: evidence from a longitudinal study. Am J Hypertens 2010;23:775-80
   PubMed Web of Science ®Google Scholar
• Bennett NM, Shea S. Hypertensive emergency: case criteria, sociodemographic profile, and previous care of 100 cases. Am J Public Health 1988;78:636-40
   PubMed Web of Science ®Google Scholar
• Sung JF, Harris-Hooker S, Alema-Mensah E, Mayberry R. Is there a difference in hypertensive claim rates among Medicaid recipients? Ethn Dis 1997;7:19-26
   PubMedGoogle Scholar
• Sarafidis P, Bakris GL. Evaluation and treatment of hypertensive urgencies and emergencies. In: Floege J, Johnson RJ, Feehaly J, editors. Comprehensive Clinical Nephrology. 4th edition. Mosby Elsevier; Philadelphia, PS; 2010. p. 445-50
   Google Scholar
• Marik PE, Varon J. Hypertensive crises: challenges and management. Chest 2007;131:1949-62
   PubMed Web of Science ®Google Scholar
• Meggs WJ. Nifedipine for hypertensive emergencies. JAMA 1997;277:787-1
   PubMedGoogle Scholar
• Messerli FH, Eslava DJ. Treatment of hypertensive emergencies: blood pressure cosmetics or outcome evidence? J Hum Hypertens 2008;22:585-6
   PubMed Web of Science ®Google Scholar
• Adams HP Jr, del Zoppo G, Alberts MJ, Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007;38:1655-711
   PubMed Web of Science ®Google Scholar
• Morgenstern LB, Hemphill JC III, Anderson C, Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2010;41:2108-29
   PubMed Web of Science ®Google Scholar
• Adams H, Adams R, Del ZG, Goldstein LB. Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke 2005;36:916-23
   PubMed Web of Science ®Google Scholar
• Cherney D, Straus S. Management of patients with hypertensive urgencies and emergencies: a systematic review of the literature. J Gen Intern Med 2002;17:937-45
   PubMed Web of Science ®Google Scholar
• Perez MI, Musini VM. Pharmacological interventions for hypertensive emergencies: a Cochrane systematic review. J Hum Hypertens 2008;22:596-607
   PubMed Web of Science ®Google Scholar
• Halpern NA, Sladen RN, Goldberg JS, Nicardipine infusion for postoperative hypertension after surgery of the head and neck. Crit Care Med 1990;18:950-5
   PubMed Web of Science ®Google Scholar
• Feldstein C. Management of hypertensive crises. Am J Ther 2007;14:135-9
   PubMedGoogle Scholar
• Lambert CR, Hill JA, Nichols WW, Coronary and systemic hemodynamic effects of nicardipine. Am J Cardiol 1985;55:652-6
   PubMed Web of Science ®Google Scholar
• Vincent JL, Berlot G, Preiser JC, Intravenous nicardipine in the treatment of postoperative arterial hypertension. J Cardiothorac Vasc Anesth 1997;11:160-4
   PubMed Web of Science ®Google Scholar
• Peacock WF, Varon J, Baumann BM, CLUE: a randomized comparative effectiveness trial of IV nicardipine versus labetalol use in the emergency department. Crit Care 2011;15:R157
   PubMed Web of Science ®Google Scholar
• Bodmann KF, Troster S, Clemens R, Schuster HP. Hemodynamic profile of intravenous fenoldopam in patients with hypertensive crisis. Clin Investig 1993;72:60-4
   PubMedGoogle Scholar
• Tumlin JA, Dunbar LM, Oparil S, Fenoldopam, a dopamine agonist, for hypertensive emergency: a multicenter randomized trial. Fenoldopam Study Group. Acad Emerg Med 2000;7:653-62
   PubMed Web of Science ®Google Scholar
• Murphy MB, Murray C, Shorten GD. Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension. N Engl J Med 2001;345:1548-57
   PubMed Web of Science ®Google Scholar
• Shusterman NH, Elliott WJ, White WB. Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function. Am J Med 1993;95:161-8
   PubMed Web of Science ®Google Scholar
• Elliott WJ, Weber RR, Nelson KS, Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension. Circulation 1990;81:970-7
   PubMed Web of Science ®Google Scholar
• Pilmer BL, Green JA, Panacek EA, Fenoldopam mesylate versus sodium nitroprusside in the acute management of severe systemic hypertension. J Clin Pharmacol 1993;33:549-53
   PubMed Web of Science ®Google Scholar
• Lund-Johansen P. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol. Drugs 1984;28(Suppl 2):35-50
   PubMedGoogle Scholar
• Pearce CJ, Wallin JD. Labetalol and other agents that block both alpha- and beta-adrenergic receptors. Cleve Clin J Med 1994;61:59-69
   PubMed Web of Science ®Google Scholar
• Olsen KS, Svendsen LB, Larsen FS, Paulson OB. Effect of labetalol on cerebral blood flow, oxygen metabolism and autoregulation in healthy humans. Br J Anaesth 1995;75:51-4
   PubMed Web of Science ®Google Scholar
• Gray RJ. Managing critically ill patients with esmolol. An ultra short-acting beta-adrenergic blocker. Chest 1988;93:398-403
   PubMed Web of Science ®Google Scholar
• Lowenthal DT, Porter RS, Saris SD, Clinical pharmacology, pharmacodynamics and interactions with esmolol. Am J Cardiol 1985;56:14F-8F
   PubMed Web of Science ®Google Scholar
• Balser JR, Martinez EA, Winters BD, Beta-adrenergic blockade accelerates conversion of postoperative supraventricular tachyarrhythmias. Anesthesiology 1998;89:1052-9
   PubMed Web of Science ®Google Scholar
• Smerling A and Gersony WM. Esmolol for severe hypertension following repair of aortic coarctation. Crit Care Med 1990;18:1288-90
   PubMed Web of Science ®Google Scholar
• Muzzi DA, Black S, Losasso TJ, Cucchiara RF. Labetalol and esmolol in the control of hypertension after intracranial surgery. Anesth Analg 1990;70:68-71
   PubMed Web of Science ®Google Scholar
• Mooss AN, Hilleman DE, Mohiuddin SM, Hunter CB. Safety of esmolol in patients with acute myocardial infarction treated with thrombolytic therapy who had relative contraindications to beta-blocker therapy. Ann Pharmacother 1994;28:701-3
   PubMed Web of Science ®Google Scholar
• Griswold WR, Reznik V, Mendoza SA. Nitroprusside-induced intracranial hypertension. JAMA 1981;246:2679-80
   PubMed Web of Science ®Google Scholar
• Kondo T, Brock M, Bach H. Effect of intra-arterial sodium nitroprusside on intracranial pressure and cerebral autoregulation. Jpn Heart J 1984;25:231-7
   PubMedGoogle Scholar
• Cohn JN, Franciosa JA, Francis GS, Effect of short-term infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure: results of a Veterans Administration cooperative study. N Engl J Med 1982;306:1129-35
   PubMed Web of Science ®Google Scholar
• Aronson S, Dyke CM, Stierer KA, The ECLIPSE trials: comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients. Anesth Analg 2008;107:1110-21
   PubMed Web of Science ®Google Scholar
• Bussmann WD, Kenedi P, von Mengden HJ, Comparison of nitroglycerin with nifedipine in patients with hypertensive crisis or severe hypertension. Clin Investig 1992;70:1085-8
   PubMedGoogle Scholar
• Ludden TM, Shepherd AM, McNay JL, Lin MS. Hydralazine kinetics in hypertensive patients after intravenous administration. Clin Pharmacol Ther 1980;28:736-42
   PubMed Web of Science ®Google Scholar
• Magee LA, Abalos E, von Dadelszen P, How to manage hypertension in pregnancy effectively. Br J Clin Pharmacol 2011;72:394-401
   PubMed Web of Science ®Google Scholar
• Huysmans FT, Thien T, Koene RA. Acute treatment of hypertension with slow infusion of diazoxide. Arch Intern Med 1983;143:882-4
   PubMed Web of Science ®Google Scholar
• Varon J, Marik PE. The diagnosis and management of hypertensive crises. Chest 2000;118:214-27
   PubMed Web of Science ®Google Scholar
• Dooley M, Goa KL. Urapidil. A reappraisal of its use in the management of hypertension. Drugs 1998;56:929-55
   PubMed Web of Science ®Google Scholar
• Brogden RN, Sorkin EM. Isradipine. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of mild to moderate hypertension. Drugs 1995;49:618-49
   PubMed Web of Science ®Google Scholar
• Maharaj B, Khedun SM, Moodley J, Intravenous isradipine in the management of severe hypertension in pregnant and nonpregnant patients. A pilot study. Am J Hypertens 1994;7:61S-3S
   PubMed Web of Science ®Google Scholar
• Espina IM, Varon J. Clevidipine: a state-of-the-art antihypertensive drug under the scope. Expert Opin Pharmacother 2012;13:387-93
   PubMed Web of Science ®Google Scholar
• Bergese SD, Puente EG. Clevidipine butyrate: a promising new drug for the management of acute hypertension. Expert Opin Pharmacother 2010;11:281-95
   PubMed Web of Science ®Google Scholar
• Prlesi L, Cheng-Lai A. Clevidipine: a novel ultra-short-acting calcium antagonist. Cardiol Rev 2009;17:147-52
   PubMed Web of Science ®Google Scholar
• Ericsson H, Fakt C, Jolin-Mellgard A, Clinical and pharmacokinetic results with a new ultrashort-acting calcium antagonist, clevidipine, following gradually increasing intravenous doses to healthy volunteers. Br J Clin Pharmacol 1999;47:531-8
   PubMed Web of Science ®Google Scholar
• Stephens CT, Jandhyala BS. Effects of fenoldopam, a dopamine D-1 agonist, and clevidipine, a calcium channel antagonist, in acute renal failure in anesthetized rats. Clin Exp Hypertens 2002;24:301-13
   PubMed Web of Science ®Google Scholar
• Segawa D, Sjoquist PO, Wang QD, Time-dependent cardioprotection with calcium antagonism and experimental studies with clevidipine in ischemic-reperfused pig hearts: part II. J Cardiovasc Pharmacol 2002;40:339-45
   PubMed Web of Science ®Google Scholar
• Noviawaty I, Uzun G, Qureshi AI. Drug evaluation of clevidipine for acute hypertension. Expert Opin Pharmacother 2008;9:2519-29
   PubMed Web of Science ®Google Scholar
• Levy JH, Mancao MY, Gitter R, Clevidipine effectively and rapidly controls blood pressure preoperatively in cardiac surgery patients: the results of the randomized, placebo-controlled efficacy study of clevidipine assessing its preoperative antihypertensive effect in cardiac surgery-1. Anesth Analg 2007;105:918-25
   PubMed Web of Science ®Google Scholar
• Pollack CV, Varon J, Garrison NA, Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for the treatment of patients with acute severe hypertension. Ann Emerg Med 2008;53:329-38
   PubMed Web of Science ®Google Scholar
• Clevidipine in the treatment of patients with acute hypertension and intracerebral hemorrhage (ACCELERATE). Available from: www.clinicaltrials.gov [Accessed 11 March 2012]
   Google Scholar
• Hiremath JS, Patki SA, Kinikar SJ, Tulpule MR. Sodium nitroprusside in hypertensive emergencies. J Assoc Physicians India 1986;34:716-17
   PubMedGoogle Scholar
• Semplicini A, Maresca A, Boscolo G, Hypertension in acute ischemic stroke: a compensatory mechanism or an additional damaging factor? Arch Intern Med 2003;163:211-16
   PubMed Web of Science ®Google Scholar
• Ahmed N, Nasman P, Wahlgren NG. Effect of intravenous nimodipine on blood pressure and outcome after acute stroke. Stroke 2000;31:1250-5
   PubMed Web of Science ®Google Scholar
• Hillis AE, Ulatowski JA, Barker PB, A pilot randomized trial of induced blood pressure elevation: effects on function and focal perfusion in acute and subacute stroke. Cerebrovasc Dis 2003;16:236-46
   PubMed Web of Science ®Google Scholar
• Schrader J, Luders S, Kulschewski A, The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke 2003;34:1699-703
   PubMed Web of Science ®Google Scholar
• Sandset EC, Bath PM, Boysen G, The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet 2011;377:741-50
   PubMed Web of Science ®Google Scholar
• Qureshi AI, Bliwise DL, Bliwise NG, Rate of 24-hour blood pressure decline and mortality after spontaneous intracerebral hemorrhage: a retrospective analysis with a random effects regression model. Crit Care Med 1999;27:480-5
   PubMed Web of Science ®Google Scholar
• Qureshi AI, Harris-Lane P, Kirmani JF, Treatment of acute hypertension in patients with intracerebral hemorrhage using American Heart Association guidelines. Crit Care Med 2006;34:1975-80
   PubMed Web of Science ®Google Scholar
• Anderson CS, Huang Y, Arima H, Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT). Stroke 2010;41:307-12
   PubMed Web of Science ®Google Scholar
• Khan IA, Nair CK. Clinical, diagnostic, and management perspectives of aortic dissection. Chest 2002;122:311-28
   PubMed Web of Science ®Google Scholar
• Estrera AL, Miller CC III, Safi HJ, Outcomes of medical management of acute type B aortic dissection. Circulation 2006;114:I384-9
   PubMed Web of Science ®Google Scholar
• Hollander JE, Carter WA, Hoffman RS. Use of phentolamine for cocaine-induced myocardial ischemia. N Engl J Med 1992;327:361
   PubMed Web of Science ®Google Scholar
• Hollander JE. The management of cocaine-associated myocardial ischemia. N Engl J Med 1995;333:1267-72
   PubMed Web of Science ®Google Scholar
• Haas CE, LeBlanc JM. Acute postoperative hypertension: a review of therapeutic options. Am J Health Syst Pharm 2004;61:1661-73
   PubMed Web of Science ®Google Scholar
• Cheung AT. Exploring an optimum intra/postoperative management strategy for acute hypertension in the cardiac surgery patient. J Card Surg 2006;21(Suppl 1):S8-S14
   PubMedGoogle Scholar
• Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1-S22
   PubMed Web of Science ®Google Scholar
• Zeller KR, Von KL, Matthews C. Rapid reduction of severe asymptomatic hypertension. A prospective, controlled trial. Arch Intern Med 1989;149:2186-9
   PubMed Web of Science ®Google Scholar
• Grossman E, Messerli FH, Grodzicki T, Kowey P. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? JAMA 1996;276:1328-31
   PubMed Web of Science ®Google Scholar